Back to search

Article

Targeted Alpha Therapy with [ <sup>225</sup> Ac]Ac-Macropa-Isatuximab for CD38-positive Hematological Malignancies

2024-11-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Hematological malignancies include diverse cancers related to immune system cells and blood-forming tissue. Treatment resistance and relapse are common despite the introduction of novel therapeutics. Following the development of the PET probe [ 89 Zr]Zr-DFO-isatuximab, targeting the overexpressed CD38 receptor, we developed [ 225 Ac]Ac-Macropa-isatuximab for targeted alpha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5dff7000-5d28-5aa6-945c-6772d0f8c137
DOI
10.1101/2024.11.01.621584
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted Alpha Therapy with [ <sup>225</sup> Ac]Ac-Macropa-Isatuximab for CD38-positive Hematological MalignanciesDOI 10.1101/2024.11.01.621584
Select a neighboring publication to make it the new centre.